BamSEC and AlphaSense Join Forces
Learn More

Zymogenetics Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.46
from 10-K 3 pages Amendment No. 2 to Facility Agreement
12/34/56
EX-10.45
from 10-K 2 pages Amendment No. 1 to Facility Agreement
12/34/56
EX-10.43
from 10-K 6 pages Amendment to License and Collaboration Agreement
12/34/56
EX-10.41
from 10-K 4 pages Amendment to U.S. Co-Promotion Agreement
12/34/56
EX-10.37
from 10-K 62 pages Third Restated License Agreement for Il-21 Embodiments by and Between Zymogenetics, Inc., and Novo Nordisk a/S Effective Date: December 3, 2009 Contents
12/34/56
EX-10.18
from 10-K 17 pages Amended and Restated Employment Agreement
12/34/56
EX-10.17
from 10-K 17 pages Amended and Restated Employment Agreement
12/34/56
EX-10.16
from 10-K 17 pages Amended and Restated Employment Agreement
12/34/56
EX-10.15
from 10-K 17 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 3 pages Amended and Restated Stock Option Grant Program for Nonemployee Directors Under the Zymogenetics 2001 Stock Incentive Plan
12/34/56
EX-10.1
from 10-Q 17 pages Employment Agreement
12/34/56
EX-10.3
from 10-Q 6 pages Separation Agreement and Release
12/34/56
EX-10.2
from 10-Q 17 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 18 pages Amended and Restated Employment Agreement
12/34/56
EX-10.5
from 10-Q 18 pages [Amended and Restated] Employment Agreement
12/34/56
EX-10.4
from 10-Q 18 pages Employment Agreement
12/34/56
EX-10.3
from 10-Q 4 pages Zymogenetics, Inc. Executive Compensation Program
12/34/56
EX-10.2
from 10-Q 31 pages License and Transfer Agreement for Il-21 Protein
12/34/56
EX-10.1
from 10-Q 111 pages Co-Development/Co-Promotion and License Agreement Relating to Type-3 Interferon Family by and Among Zymogenetics, Inc. and Zymogenetics, LLC and Bristol-Myers Squibb Company Execution Date: January 12, 2009
12/34/56
EX-10.43
from 10-K 13 pages Release and License Agreement
12/34/56